1. Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors.
- Author
-
Gherman, Madalina Luciana, Zanoaga, Oana, Budisan, Liviuta, Raduly, Lajos, and Berindan-Neagoe, Ioana
- Subjects
DOXORUBICIN ,FEMALE dogs ,EPITHELIAL-mesenchymal transition ,PHENOTYPIC plasticity ,CELL cycle ,TUMOR treatment - Abstract
Simple Summary: Due to the limited options in mammary tumor treatments, the following study demonstrates the efficiency of Doxorubicin on canine mammary tumor therapy and in the alteration of expression of the key genes involved in the epithelial-to-mesenchymal transition processes. Canine mammary tumors represent one of the leading malignant pathologies in female dogs, displaying the importance of efficient therapeutic findings, besides the golden-standard surgery, able to limit the development of the disease. Studies in human cancers demonstrated that Doxorubicin presents a good effect in different biological processes like apoptosis, autophagy, the cell cycle, cell invasion, and the epithelial-to-mesenchymal transition. This study followed the effects of Doxorubicin on two canine mammary cancer cell lines P114 and CMT-U27. Doxorubicin treatment in both cell lines shows an inhibitory effect in cell proliferation and an alteration in expression of the EMT-related genes. The obtained results provide valuable information for revealing the link between Doxorubicin, phenotypic changes, and proliferation dynamics in canine mammary tumor models. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF